Table 1.

Baseline clinical and biochemical and arterial parametersa

VariablePatients with ESRD (n = 52)
Age (yr)58.0 ± 1.9
SBP (mmHg)138.0 ± 3.0
DBP (mmHg)76.0 ± 1.6
Hemoglobin (g/L)116.0 ± 1.9
CRP (mg/L)4.8 ± 0.5 (4.0)
Serum albumin (g/L)38.0 ± 0.40
Total cholesterol (mMol/L)4.42 ± 0.16
Serum calcium (mMol/L)2.31 ± 0.02
Serum Ca2+ (mMol/L)1.17 ± 0.08
Serum phosphate (mMol/L)1.58 ± 0.06
Ca × PO4 product (mMol2/L2)3.94 ± 0.03
Serum 25(OH)D3 (μg/L)14.2 ± 1.0 (13.5)
Serum 1,25(OH)2D3 (ng/L) (n = 40)17.4 ± 1.0 (17.0)
PTH (pg/ml)345 ± 37 (256)
Aortic PWV (m/s)10.30 ± 0.37
BA distensibility (kPa10−1 × 10−3)2.75 ± 0.20
FMD (ΔBA diameter % of baseline)2.76 ± 0.40
  • a Data are means ± SEM and sometimes (median). 1,25(OH)2D3, 1,25-dihydroxyvitamin D3; 25(OH)D3, 25-hydroxyvitamin D; BA, brachial artery; CRP, C-reactive protein; DBP, diastolic BP; FMD, flow-mediated dilation; PTH, parathormone; PWV, pulse wave velocity; SBP, systolic BP.